CD274 and pachyonychia congenita: Unfortunately, although multiple studies showed that high PD-L1 expression also detected in PC is associated with poor outcomes, suggesting that targeting PD-1/PD-L1 interaction may have therapeutic benefit in these patients [11,113], promising preclinical findings have not translated into clinical success when ICIs were tested as single agents in PC patients [114,115].